Patient Capital Management is a Baltimore asset manager founded in 2020 by Samantha McLemore, CFA — Bill Miller's long-time co-manager (working together since 2002, running the flagship Opportunity Equity strategy since 2014). Continuing the Miller-school contrarian tradition, it practices "time arbitrage": exploiting behavioral mispricing to concentrate in controversial growth names (tech, healthcare, Bitcoin-related) at deep discounts to intrinsic value. Its site preserves Bill Miller's complete 1995-2022 market letters, alongside ongoing quarterly letters and webinars.

This report breaks down U.S. markets in early 2024: stocks rallied (S&P 500 up 10.6%) despite sticky inflation (core PCE at 2.8%) and rising bond yields. The Magnificent Seven (Apple, Tesla, Nvidia, etc.) started splitting—Nvidia and Meta surged, while Apple and Tesla lagged. Bonds lost ground, but energy, telecoms, gold, and Bitcoin gained. For everyday investors, it’s a nudge to diversify beyond tech giants, watch rate risks, and consider commodities. Worth reading because it flags shifting market dynamics before they trip you up.
Patient Capital Research notes that since the October 2023 low, the market has risen for the fifth consecutive month, with the first quarter of 2024 total return performance ranking as the 15th best start since 1927. The core view is that market breadth has expanded, but the Magnificent 7 have shown
This chapter reviews the overall performance of the U.S. capital markets in the first quarter of 2024, focusing on the equity market's continued uptrend from the October 2023 lows, and analyzes sticky inflation, rising interest rates, and the divergent performance across asset classes (equities, bonds, commodities, cryptocurrencies). The report notes that market breadth has expanded, but significant divergence has emerged within the Magnificent 7.
The report's core investment argument is that after the market's 15th-best start since 1927, upward momentum remains strong, but the structure is shifting. Counterintuitive judgments include:
The report supports its views with the following data and comparisons:
Comparative Data Table:
| Asset/Index | 2024 Q1 Total Return |
|---|---|
| S&P 500 Index | +10.6% |
| Nasdaq Composite Index | +9.3% |
| Dow Jones Industrial Average | +6.1% |
| Russell 1000 Growth Index | +11.4% |
| Russell 1000 Value Index | +9.0% |
| Russell 2000 Index | +5.2% |
| Bloomberg Aggregate Bond Index | -0.8% |
| 20+ Year U.S. Treasury Bond Index | -3.8% |
| U.S. Dollar Index | +3.2% |
| Gold | +6.0% |
| WTI Crude Oil | +16.1% |
| Bitcoin | +68.6% |
The report explicitly references the following companies, providing key data and judgments: